Skip to main content
Jason Karlawish, MD, Geriatrics, Philadelphia, PA

JasonHKarlawishMD

Geriatrics • Philadelphia, PA

Professor of Medicine, Medical Ethics and Health Policy, and Neurology at the University of Pennsylvania Perelman School of Medicine Director of the Penn Neurodegenerative Disease Ethics and Policy Program Associate Director of the Clinical Core and Co-Associate Director of the Alzheimer’s Disease Core Center Co-Director of the Penn Memory Center Director of Alzheimer’s Disease Core

Join to view full profile

Dr. Karlawish is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Karlawish's full profile

Already have an account?

  • Office

    3615 Chestnut St
    Ralston Penn Center
    Philadelphia, PA 19104
    Phone+1 215-662-2746

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Geriatric Medicine (Internal Medicine), 1995 - 1997
  • Johns Hopkins University/Bayview Medical Center
    Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1991 - 1994
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1991

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1997 - 2024
  • IL State Medical License
    IL State Medical License 1994 - 1999
  • MD State Medical License
    MD State Medical License 1993 - 1994
  • American Board of Internal Medicine Geriatric Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Desktop Medicine and the Practice of Wealth Care  
    Jason Karlawish, MD, JAMA Internal Medicine
  • Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment  
    Jeffrey M Burns, Keith A Johnson, Reisa A Sperling, Jason Karlawish, JAMA Neurology
  • Study Partners Should Be Required in Preclinical Alzheimer’s Disease Trials  
    Joshua D Grill, Jason Karlawish, BioMed Central

Authored Content

  • The FDA Needs a Risk Evaluation and Mitigation Strategy for Alzheimer’s Drug LecanemabJune 2023
  • How Can the Latest Alzheimer’s Therapy Reach Patients? Follow This Trustworthy ProcessOctober 2022
  • We Can’t Drug Our Way Out of Despair over Alzheimer’s | OpinionAugust 2021
  • Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive ImpairmentAugust 2020
  • How Bill Gates Could Transform Alzheimer's DiseaseAugust 2018
  • Join now to see all

Press Mentions

  • Light Pollution at Night May Increase the Risk of Alzheimer’s, Study Finds
    Light Pollution at Night May Increase the Risk of Alzheimer’s, Study FindsSeptember 6th, 2024
  • Light Pollution at Night May Increase Risk of Alzheimer’s, Study Finds
    Light Pollution at Night May Increase Risk of Alzheimer’s, Study FindsSeptember 6th, 2024
  • New Breakthrough Blood Testing Technology Can Accurately Diagnose Alzheimer’s in 90% of Dementia Cases
    New Breakthrough Blood Testing Technology Can Accurately Diagnose Alzheimer’s in 90% of Dementia CasesJuly 28th, 2024
  • Join now to see all

Grant Support

  • Parkinsons Disease And Research Consent CapacityNational Institute Of Neurological Disorders And Stroke2009–2011
  • Core--Education And Information TransferNational Institute On Aging2006–2010
  • Consent Methods And Participation In Geriatric Clinical ResearchNational Institute Of Mental Health2007–2009
  • Understanding Attitudes About Research Advance PlanningNational Institute Of Mental Health2006
  • Improving Informed Consent In Alzheimer Disease ResearchNational Institute On Aging2004–2006
  • Core-- Education And Information TransferNational Institute On Aging2001–2002
  • Community Equipoise And The Ethics Of Clinical ResearchNational Institute On Aging1998–2002

Professional Memberships

Dr. Jason Karlawish, Dr. Jason Karlawish, MD, Dr. J Karlawish, Dr. Jason H Karlawish